AP134A - Plasmodium circumsporozoite protein analogos lacking repeat sequences. - Google Patents

Plasmodium circumsporozoite protein analogos lacking repeat sequences. Download PDF

Info

Publication number
AP134A
AP134A APAP/P/1990/000176A AP9000176A AP134A AP 134 A AP134 A AP 134A AP 9000176 A AP9000176 A AP 9000176A AP 134 A AP134 A AP 134A
Authority
AP
ARIPO
Prior art keywords
protein
native
analog
sequence
plasmodium
Prior art date
Application number
APAP/P/1990/000176A
Other languages
English (en)
Other versions
AP9000176A0 (en
Inventor
Philip J Baar
Ian C Bathurst
Helen L Gibson
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Publication of AP9000176A0 publication Critical patent/AP9000176A0/xx
Application granted granted Critical
Publication of AP134A publication Critical patent/AP134A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • C07K16/205—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
APAP/P/1990/000176A 1989-04-11 1990-04-11 Plasmodium circumsporozoite protein analogos lacking repeat sequences. AP134A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33628889A 1989-04-11 1989-04-11

Publications (2)

Publication Number Publication Date
AP9000176A0 AP9000176A0 (en) 1990-04-30
AP134A true AP134A (en) 1991-07-16

Family

ID=23315419

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1990/000176A AP134A (en) 1989-04-11 1990-04-11 Plasmodium circumsporozoite protein analogos lacking repeat sequences.

Country Status (10)

Country Link
EP (2) EP0467965A4 (de)
JP (1) JPH04506064A (de)
AP (1) AP134A (de)
AU (1) AU635265B2 (de)
CA (1) CA2051432A1 (de)
IL (1) IL94063A0 (de)
NZ (1) NZ233255A (de)
PT (1) PT93721A (de)
WO (1) WO1990011775A1 (de)
ZA (1) ZA902741B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5362623A (en) * 1991-06-14 1994-11-08 The John Hopkins University Sequence specific DNA binding by p53
DE19544233A1 (de) * 1995-11-28 1997-06-05 Hoechst Ag Verfahren zur Nutzung des Hefe-ADH II-Promotorsystems zur biotechnologischen Produktion heterologer Proteine in hohen Ausbeuten
WO2006088597A2 (en) 2005-01-18 2006-08-24 Walter Read Army Institute Of Research A plasmodium vivax hybrid circumsporozoite protein and vaccine
US9169304B2 (en) 2012-05-01 2015-10-27 Pfenex Inc. Process for purifying recombinant Plasmodium falciparum circumsporozoite protein

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0289110A2 (de) * 1987-02-02 1988-11-02 Swiss Serum and Vaccine Institute Berne Konjugierter Malaria-Impfstoff
DE3830565A1 (de) * 1987-09-11 1989-03-23 Eniricerche Spa Polypeptid-sequenzen, die mit immunologischer aktivitaet ausgestattet sind
WO1989002924A1 (en) * 1987-10-02 1989-04-06 Praxis Biologics, Inc. Vaccines for malaria

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4707357A (en) * 1984-06-26 1987-11-17 The United States Of America As Represented By The Secretary Of The Army Immunologically active peptides capable of inducing immunization against malaria and genes encoding therefor
DE3686178T2 (de) * 1985-02-07 1993-03-11 Smithkline Beckman Corp Malaria-impfstoff.
EP0229829B1 (de) * 1985-07-12 1995-02-22 New York University Mit dem plasmodium-vivax-circumsporozoit-protein übereinstimmendes immunogenes peptidantigen
EP0254862A1 (de) * 1986-06-26 1988-02-03 BEHRINGWERKE Aktiengesellschaft Impfstoffe gegen protozoischen Parasiten
IL85905A0 (en) * 1987-03-30 1988-09-30 Univ New York Immunogenic recombinant yeast expression product and method for purifying it
CA2015722A1 (en) * 1989-05-03 1990-11-03 Mitchell S. Gross Malaria vaccine
CA2031468A1 (en) * 1989-12-08 1991-06-09 Mitchell S. Gross Malaria vaccine

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0289110A2 (de) * 1987-02-02 1988-11-02 Swiss Serum and Vaccine Institute Berne Konjugierter Malaria-Impfstoff
DE3830565A1 (de) * 1987-09-11 1989-03-23 Eniricerche Spa Polypeptid-sequenzen, die mit immunologischer aktivitaet ausgestattet sind
WO1989002924A1 (en) * 1987-10-02 1989-04-06 Praxis Biologics, Inc. Vaccines for malaria

Also Published As

Publication number Publication date
EP0467965A1 (de) 1992-01-29
JPH04506064A (ja) 1992-10-22
CA2051432A1 (en) 1990-10-12
PT93721A (pt) 1990-11-20
EP0392820A3 (de) 1990-12-27
WO1990011775A1 (en) 1990-10-18
ZA902741B (en) 1991-03-27
NZ233255A (en) 1993-02-25
EP0392820A2 (de) 1990-10-17
AU5524290A (en) 1990-11-05
AP9000176A0 (en) 1990-04-30
EP0467965A4 (en) 1992-04-15
IL94063A0 (en) 1991-01-31
AU635265B2 (en) 1993-03-18

Similar Documents

Publication Publication Date Title
EP1015596B1 (de) Hiv-1 tat und/oder nef enthaltende fusionsproteine
ES2443216T3 (es) Proteínas de fusión que comprenden polipéptidos de VPH y péptidos de inmunopotenciación de tratamiento y prevención del cáncer cervicouterino
NO324089B1 (no) Hybrid nukleinsyremolekyl for fremstilling av lipiderte rekombinante proteiner fra Borrelia-arter.
JP2022046617A (ja) 異種ポリペプチドを含むＣｙａＡベースのキメラタンパク質及び免疫応答の誘導におけるその使用
JP4573773B2 (ja) マラリア・ワクチン
US5830457A (en) Recombinant beta-lactamase, usable as carrier molecule in immunogenic compositions
HU211205B (en) Method for the preparation of anti-coccidial recombinant protein, recombinant dna for preparing the same, recombinant plasmid, recombinant vaccine virus and transformed e. coli cells and vaccine containing this recombinant protein
AP134A (en) Plasmodium circumsporozoite protein analogos lacking repeat sequences.
ES2244993T3 (es) Metodo recombinante para la preparacion de un antigeno completo de malaria gp190/msp1.
AU714808B2 (en) Modified polypeptides for enhanced immunogenicity
AU7514494A (en) Method for expression and purification of p2 protein from haemophilus influenzae type b
EP2763694B1 (de) Herstellung eines cysteinreichen proteins
JP3135060B2 (ja) ヘモフィルスインフルエンザｂ型菌の外皮膜タンパク質Ｐ２の部分断片を用いた接合体
HUT51332A (en) Process for expressing p.falciparum cirkumsporozoita protein by yeast
US5395614A (en) Protective Plasmodium falciparum hybrid proteins which contain part-sequences of the malaria antigens HRPII and SERP, the preparation and use thereof
US5273744A (en) Vaccines for the protection of animals against theileria infection
US20060204514A1 (en) Expression of hydrophobic proteins
NZ226025A (en) Plasmodium falciparum merozoite epitope peptides, peptide conjugates, dna and antibodies
GB2232675A (en) Stable forms of antigenic taenia ovis polypeptides
JPS63503512A (ja) 新規ワクチン
US20080089929A1 (en) Fusion proteins comprising hiv-1 tat and/or nef proteins
KR102501639B1 (ko) 신규한 세포 내 단백질 전달 방법
JPWO1997036924A1 (ja) 新規な融合タンパク質、その遺伝子、組み換えベクター、及び組み換えウイルスとその利用
CN121698968A (zh) 大别班达病毒的重组抗原蛋白及其亚单位疫苗
US5366728A (en) Stable forms of antigenic Taenia ovis polypeptides